sociodemographic characteristics

Related by string. * socio demographic . sociodemographics . Sociodemographic . Socio demographic : sociodemographic factors . sociodemographic variables . sociodemographic / CHARACTERISTICS . Characteristics . Characteristic : Market Characteristics chapter . demographic characteristics . distinguishing characteristics . distinguishing characteristic . defining characteristic * *

Related by context. All words. (Click for frequent words.) 77 sociodemographic factors 75 sociodemographic variables 75 sociodemographic 73 sociodemographics 72 psychiatric comorbidities 71 Sociodemographic 70 Socio demographic 70 multiple logistic regression 70 APOE genotype 70 multivariate analyzes 69 neurocognitive functioning 69 covariates 69 psychiatric morbidity 69 comorbid depression 69 univariate analyzes 68 depressive symptomatology 68 CHD mortality 68 psychiatric comorbidity 68 socio demographic 68 HRQOL 67 limiting generalizability 67 multivariable analysis 67 premorbid 67 antenatal depression 67 covariate 67 comorbid conditions 67 multivariable analyzes 67 bivariate 66 comorbidity 66 bivariate analyzes 66 logistic regression analyzes 66 confounders 66 Socioeconomic status 66 affective disorders 66 Univariate analysis 66 Depressive symptoms 66 #q# deletion syndrome 66 clinico pathological 65 comorbid disorders 65 comorbid anxiety 65 suicide ideation 65 meta regression 65 autonomic dysfunction 65 logistic regression model 65 multivariate logistic regression 65 thyrotropin levels 65 HRQoL 65 BMI z 65 CVD mortality 65 Logistic regression 65 socioeconomic deprivation 65 tumor histology 65 psychosocial functioning 65 Suicidal ideation 65 confounder 65 generalized estimating 65 % CI #.#-#.# [008] 65 noncognitive 65 logistic regression models 65 comorbid illnesses 65 familial clustering 65 retrospective cohort 65 odds ratios ORs 65 somatoform disorders 64 diabetes mellitus hypertension 64 nonpsychotic 64 logistic regression analysis 64 salivary cortisol 64 alexithymia 64 socioeconomic variables 64 psychosocial variables 64 serum lipid levels 64 socioeconomic status SES 64 Univariate 64 demographic variables 64 comorbid diagnoses 64 multivariable adjusted 64 HRQL 64 affective psychosis 64 tertiles 64 adverse perinatal 64 MMSE score 64 multivariate adjustment 64 NHANES III 64 Charlson comorbidity index 64 serum estradiol 64 shorter telomere length 64 CHD CVD 64 Symptom severity 64 potential confounders 64 prepregnancy BMI 64 echocardiographic parameters 64 familial aggregation 64 neurocognitive function 63 Subgroup analyzes 63 strongest predictors 63 univariate analysis 63 postdischarge 63 Neuroticism 63 hypertension diabetes mellitus 63 Comorbid 63 meta analytic review 63 comorbid psychiatric 63 conditional logistic regression 63 nondepressed 63 generalizability 63 posttreatment 63 suicide attempters 63 Logistic regression analysis 63 hormone receptor status 63 unmeasured confounders 63 EQ 5D 63 neurocognitive impairment 63 potential confounding variables 63 % CI #.#-#.# [006] 63 depressive symptom 63 MetS 63 EGFR mutation status 63 syndromic 63 Heritability 63 subclinical atherosclerosis 63 serum GGT 63 MMSE scores 63 poststroke 63 Multivariate analyzes 63 Multivariate analysis 63 psychosocial distress 63 logistic regression 62 schizophrenia schizoaffective disorder 62 Comorbidity 62 univariate 62 preintervention 62 coexisting illnesses 62 elevated serum ALT 62 Main Outcome Measure 62 confidence intervals CIs 62 antipsychotic prescribing 62 clinicopathological 62 Multiple logistic regression 62 tumor subtype 62 nonpsychiatric 62 depression suicidal ideation 62 psychiatric inpatients 62 fasting insulin 62 abnormal lipid 62 elevated fasting glucose 62 abdominal adiposity 62 MDRD 62 postoperative AF 62 spirometric 62 multivariable adjustment 62 internalizing disorders 62 postintervention 62 CORE OM 62 cardio respiratory fitness 62 gallstone disease 62 comorbidities 62 hsCRP levels 62 colorectal adenoma 62 semistructured interviews 62 NAMCS 62 obesity sedentary lifestyle 62 somatization disorder 62 Insulin sensitivity 62 nonadherence 62 NIHSS score 62 HbA1C levels 62 CLBP 62 posttransplant 62 genotype phenotype 62 waist circumference WC 61 affective psychoses 61 nonfasting triglyceride levels 61 HIV HCV coinfected 61 persistency mortality 61 hip BMD 61 prospectively stratified 61 cerebral oxygenation 61 parous women 61 comorbid 61 IPAH 61 mortality morbidity 61 socioeconomic status 61 diabetes hypertension hyperlipidemia 61 albumin excretion 61 practitioners internists 61 SGRQ 61 guideline concordant 61 BMI waist circumference 61 residual confounding 61 socioeconomic characteristics 61 estimated GFR 61 p = .# [002] 61 somatic symptoms 61 Socioeconomic factors 61 biopsychosocial 61 mean ± SEM 61 psychosocial stressors 61 carotid IMT 61 Poisson regression 61 subscale scores 61 postmenopausal hormone 61 estimated glomerular filtration 61 Heavy menstrual bleeding 61 coronary calcification 61 fibroids endometriosis 61 multivariate Cox 61 syndromal 61 LUTS 61 nonobese 61 EORTC QLQ C# 61 euthymic patients 61 histological subtype 61 NLSY 61 unmeasured confounding 61 impaired glucose metabolism 61 THIS STUDY analyzed 61 serum vitamin D 61 psychiatric outpatients 61 inflammatory biomarkers 61 Comorbidities 61 Primary endpoints 61 Charlson Comorbidity Index 61 multiple linear regression 61 noncardiovascular mortality 61 urolithiasis 61 confounding variables 61 adiponectin concentrations 61 subthreshold depression 61 nonadherent 60 dietary calcium intake 60 elevated ALT 60 unmeasured factors 60 β = 60 prepregnancy 60 GH deficiency 60 comorbid substance 60 serum BDNF 60 antioxidant supplementation 60 venous thromboembolic disease 60 Personality traits 60 intima media thickness 60 elevated depressive symptoms 60 serum creatinine levels 60 prognostic variables 60 VLBW infants 60 albumin excretion rate 60 nephrolithiasis 60 cerebral microbleeds 60 euthymic 60 Framingham Offspring 60 ski lls 60 depressive symptoms 60 Meta analyzes 60 neurodevelopmental outcomes 60 CHADS2 60 demographic characteristics 60 serum leptin 60 dysglycemia 60 Multivariate logistic regression 60 chronicity 60 potentially modifiable 60 convergent validity 60 meta analytic 60 visceral adiposity 60 plasma homocysteine 60 comorbid psychiatric disorders 60 gestational diabetes mellitus 60 lifetime abstainers 60 anthropometric measures 60 Descriptive statistics 60 advanced neoplasia 60 perinatal complications 60 beta carotene supplementation 60 hydroxyvitamin D concentrations 60 Baseline characteristics 60 symptom exacerbation 60 Cognitive impairment 60 interobserver 60 perinatal outcomes 60 interindividual variability 60 triacylglycerol concentrations 60 Main Outcome Measures 60 clinicopathologic 60 subclinical hypothyroidism 60 modifiable lifestyle 60 mild renal insufficiency 60 confidence interval #.#-#.# 60 mania hypomania 60 Endothelial function 60 postoperative complication 60 colorectal neoplasia 60 multivariable logistic regression 60 stepwise logistic regression 60 antiretroviral naïve 60 metabolite concentrations 60 NHAMCS 60 glycated hemoglobin HbA1c 60 T1DM 60 poststroke depression 60 cardio metabolic 60 Secondary efficacy endpoints 60 recurrent UTI 60 MTHFD1L gene 60 ethnicity socioeconomic status 60 serum parathyroid hormone 60 Erectile function 60 VLBW 59 opioid prescribing 59 serum IGF 59 ELBW infants 59 strongest predictor 59 highest tertile 59 mammographic density 59 colorectal cancer incidence 59 #q#.# deletion syndrome 59 schizophreniform disorder 59 aged ≥ 59 generalisability 59 ANCOVA 59 Gestational 59 seropositivity 59 neurosensory 59 attain statistical significance 59 logistic regressions 59 nulliparous women 59 CYP#D# genotype 59 severe hypoglycaemia 59 habitual snoring 59 retrospectively analyzed 59 Reynolds Risk Score 59 preoperative intraoperative 59 antidiabetic medications 59 coinfected patients 59 Factors influencing 59 TT genotype 59 Prehypertension 59 Depressive Symptoms 59 nondiabetic patients 59 nonfasting triglycerides 59 symptomatic intracerebral hemorrhage 59 serum homocysteine 59 preoperative PSA 59 Fasting glucose 59 prognostic indicators 59 Schaffir 59 choline intake 59 hematological parameters 59 fragility fracture 59 serum PTH 59 chlamydial infection 59 Sleep disturbances 59 DAS# scores 59 irregular menses 59 umol L 59 dysthymia 59 antidiabetic medication 59 prospective longitudinal 59 neurobehavioural 59 noncardiac 59 CI -#.# 59 hematopoietic cancers 59 anthropometric measurements 59 lipid lowering agents 59 multivariate analysis 59 bivariate analysis 59 cognitive affective 59 perinatal morbidity 59 arterial stenosis 59 BMI percentiles 59 Child Behavior Checklist 59 pain catastrophizing 59 nondemented 59 somatoform disorder 59 Mood disorders 59 de novo AML 59 hydroxyvitamin D levels 59 nonvertebral fracture 59 fasting serum 59 intraobserver 59 impaired cognition 59 Cognitive behavioral 59 internalizing behaviors 59 erection hardness 59 diabetes mellitus DM 59 histologic subtype 59 HOMA IR 59 abnormal lipid levels 59 neuropsychological assessments 59 carotid bruit 59 psychoeducation 59 genotypic resistance 59 HbA 1c levels 59 Adverse effects 59 Cystatin C 59 carotid plaques 59 Multivariate analysis revealed 58 atherothrombotic 58 BPS IC 58 plasma adiponectin 58 neurodevelopmental outcome 58 postoperative mortality 58 5 HTTLPR genotype 58 callous unemotional traits 58 BEXXAR Therapeutic Regimen 58 menstrual irregularity 58 endometrial thickness 58 CPAP adherence 58 gait disturbance 58 nicotine metabolite 58 Kaplan Meier estimates 58 explanatory variables 58 prevalences 58 extramedullary 58 baseline LDH 58 HER2 overexpression 58 nonfatal MI 58 serum lipids 58 Excessive daytime sleepiness 58 microalbumin 58 HIV uninfected 58 neuropsychological functioning 58 aldosterone antagonist 58 clinicopathological features 58 myocardial viability 58 corticosteroid dose 58 serum phosphate 58 Genetic predisposition 58 MS DRG 58 serum cotinine 58 venlafaxine XR 58 subscales 58 psychoeducational 58 Breslow thickness 58 intracranial stenosis 58 metabolic dysregulation 58 Bonferroni correction 58 Complication rates 58 hyperhomocysteinemia 58 abnormal lipids 58 DVT PE 58 gastric cardia 58 cardiorespiratory fitness 58 neurocognition 58 arterial thickening 58 #q# deletion 58 primary aldosteronism 58 untreated psychosis 58 prostate cancer CaP 58 serum folate 58 hyperactivity inattention 58 subclinical disease 58 causal pathway 58 BMD measurements 58 Apgar scores 58 ADCS CGIC 58 suboptimal adherence 58 STEP BD 58 decompensated cirrhosis 58 Subgroup analysis 58 etiologic 58 Glomerular Filtration Rate 58 TF CBT 58 undergone bariatric surgery 58 multivariate regression 58 urine albumin 58 overt nephropathy 58 multivariable Cox 58 bronchopulmonary dysplasia BPD 58 postoperative delirium 58 peripartum 58 somatization 58 Atkins dieters cardiovascular 58 inpatient hospitalization 58 CI = 58 Edinburgh Postnatal Depression 58 plasma folate 58 serum folate concentrations 58 nondiabetic 58 oxygen desaturation 58 System IPSS 58 atherosclerotic cardiovascular 58 PLX STROKE targeting 58 Fasting blood glucose 58 congenital toxoplasmosis 58 CARDIA 58 BRCA testing 58 nonalcoholic steatohepatitis 58 Genetic variants 58 plasma homocysteine levels 58 psychopathological symptoms 58 testicular germ cell 58 glycosylated hemoglobin HbA1c 58 confidence interval CI 58 neuropsychological deficits 58 affective disorder 58 plasma lipids 58 postoperative pulmonary 58 Calcium intake 58 obstructive coronary artery 58 plasma selenium 58 FeNO 58 tic severity 58 convulsive disorders 58 unfavorable prognostic 58 impaired insulin secretion 58 fatal IHD 58 neuropsychological assessment 58 diagnosing ADHD 58 symptom severity 58 nutrient intakes 58 HER2 expression 58 lipid profiles 58 STRATEGY FOR AN OPEN 58 vitamin D inadequacy 58 β blockers 58 psychodynamic therapy 58 arterial oxygen saturation 58 elevated creatinine 58 CARDIA study 58 intracerebral haemorrhage 58 statistically nonsignificant 58 hyper IgE syndrome 58 Serum calcium 58 anovulatory infertility 58 cytologic 58 statistically significant predictor 58 lowest tertile 58 serum retinol 58 multivariate regression analysis 58 Suicidal thoughts 57 Polypharmacy 57 serum selenium 57 neuropsychiatric symptoms 57 ICD therapy 57 schizotypal 57 elevated LDL cholesterol 57 deCODE BreastCancer TM 57 androgen deficiency 57 de ath 57 thyroid hormone levels 57 intact parathyroid hormone 57 severe periodontitis 57 daytime somnolence 57 % CI #.#-#.# [003] 57 orofacial clefts 57 preeclamptic 57 Dietary habits 57 alanine aminotransferase ALT 57 amisulpride 57 arterial thromboembolic events 57 nonacute 57 SLNB 57 confusional 57 thrombophilia 57 BRFSS 57 Genetic susceptibility 57 inversely associated 57 left ventricular diastolic 57 nonfasting 57 etiological 57 longitudinal cohort study 57 Observational studies 57 BMI percentile 57 elevated IOP 57 nonpharmacologic 57 hyperlipidaemia 57 postoperative morbidity 57 DSM IV Axis 57 testicular tumors 57 thyrotropin 57 Nicotine dependence 57 = #.#-#.# 57 acute subacute 57 adenotonsillectomy 57 perioperative mortality 57 tertile 57 untreated OSA 57 lymphocyte subsets 57 dyslipidaemia 57 serum markers 57 hemodynamic measurements 57 proband 57 esophageal reflux 57 transferrin saturation 57 CYP#D# inhibitor 57 perioperative complications 57 asymptomatic PAD 57 lipid lowering medications 57 Brief Psychiatric 57 fraternal twin pairs 57 prospective observational studies 57 glycosylated hemoglobin levels 57 Female Sexual Function 57 prolactin levels 57 hippocampal volumes 57 potentially confounding variables 57 cardiac malformations 57 androgen excess 57 COMT genotype 57 SGPT 57 carotid atherosclerosis 57 specific antigen PSA 57 baseline CD4 57 LV dysfunction 57 biochemical recurrence 57 SRBD 57 EMPOWER TM 57 Index CDAI 57 QIDS SR 57 nonpregnant women 57 plasma cortisol 57 differential gene expression 57 body fatness 57 Nonmedical 57 Heterogeneity 57 carotid intima media 57 liver histology 57 atopic 57 APOE ε4 57 lipid elevations 57 Multivariable logistic regression 57 recurrent venous thromboembolism 57 Hb A1C 57 elevated LDH 57 plasma creatinine 57 neurodevelopmental impairment 57 endogenous hormones 57 Medication adherence 57 liver transplant recipients 57 postmenopausal hormones 57 underwent CABG 57 chorioamnionitis 57 comorbid ADHD 57 FEV ^ sub 57 highest quintile 57 predictive validity 57 pretransplant 57 Montgomery Åsberg Depression 57 pharmacodynamic parameters 57 SSRI SNRI 57 subclinical hyperthyroidism 57 lipid parameters 57 elevated CRP 57 hyperlipidemia hypertension 57 atherogenic dyslipidemia 57 observable characteristics 57 glomerular filtration rate 57 GABRA2 57 calcaneal fractures 57 nonvertebral fractures 57 MDRD equation 57 carotid stenosis 57 civilian noninstitutionalized population 57 PON1 activity 57 Swedish Mammography Cohort 57 hypovitaminosis D 57 urinary BPA 57 stratifying patients 57 perinatal depression 57 cervicitis 57 androgen depletion 57 observational cohort 57 Kaplan Meier curve 57 Multicenter AIDS 57 serum PSA 57 hormonal abnormalities 57 P = .# 57 hypertension cardiovascular disease 57 Singh Manoux 57 antiphospholipid antibodies 57 aortic atherosclerosis 57 interrater reliability 57 overnight polysomnography 57 coronary artery calcification 57 opioid dependent 57 chronic prostatitis chronic 57 relapsed MM 57 hypochondriasis 57 allele frequencies 57 T2DM 57 poor metabolizers 57 isolated systolic hypertension 57 hepatorenal syndrome 57 psychiatric diagnoses 57 unfavorable cytogenetics 57 hydroxyvitamin D 57 ICD implantation 57 anthropometric 57 cardiac autonomic 57 nonalcoholic steatohepatitis NASH 57 APOE e4 57 serum lipid 57 ALI ARDS 57 hypercoagulable 57 HRCT 57 onset diabetes mellitus 57 DLQI 57 neurocognitive dysfunction 57 endometriosis ovarian cysts 57 cardiopulmonary diseases 57 intraclass correlation coefficients 57 extrapyramidal symptoms 57 Homocysteine levels 57 apnea hypopnea 57 Kadan Lottick 57 parous 57 advanced adenoma 57 diastolic pressures 56 WOMAC scores 56 fractional anisotropy 56 obesity insulin resistance 56 prospectively enrolled 56 KIF6 carriers 56 SIADH 56 Scale EDSS score 56 conducted retrospective cohort 56 chi squared 56 obstructive CAD 56 carbohydrate intolerance 56 Modifiable risk 56 prolactin elevation 56 Triglyceride levels 56 CC genotype 56 % CI #.#-#.# [005] 56 cecal intubation 56 posttest 56 Depressive disorders 56 Exacerbations 56 corneal thickness 56 glucose insulin 56 phytoestrogen intake 56 loop diuretics 56 vascular dysfunction 56 eNO 56 ELBW 56 invasive ductal breast cancer 56 subsyndromal 56 autistic traits 56 femoral neck fracture 56 interobserver reliability 56 cardiovascular disease hypertension 56 serum lactate 56 atherothrombotic disease 56 acute cholecystitis 56 coagulation abnormalities 56 puerperal psychosis 56 colorectal adenomas 56 hippocampal volume 56 baseline HbA1c 56 metaanalysis 56 geriatric syndromes 56 ratio WHR 56 oral hypoglycemic agents 56 prostate carcinogenesis 56 Marital status 56 aminotransferase levels 56 leukocyte counts 56 inhospital mortality 56 probands 56 ß blockers 56 elevated homocysteine 56 undiagnosed celiac disease 56 TEAEs 56 linear regression analyzes 56 exploratory endpoints 56 serum cotinine levels 56 DHEA supplementation 56 subtrochanteric 56 carotid plaque 56 pharmacological therapy 56 Venous thromboembolism 56 Mental disorders 56 nulliparous 56 magnesium intake 56 plasma lipid 56 psychotherapeutic drugs 56 thiopurine 56 narcolepsy cataplexy 56 NHANES #-# 56 chronic periodontitis 56 NESARC 56 Correlates 56 deep venous thromboses 56 monoclonal gammopathy 56 overactive bladder symptoms 56 SF #v# 56 hypoactive 56 cranial irradiation 56 baseline A1C 56 Wisconsin Sleep Cohort 56 EDSS scores 56 electrophysiologic 56 MADRS score 56 coronary revascularization procedures 56 randomized controlled trials RCTs 56 dietary DHA 56 prospective cohort 56 TMP SMX 56 macroalbuminuria 56 DSM IV diagnosis 56 menarche 56 Skin sterol 56 initiating antiretroviral therapy 56 abstinent alcoholics 56 asymptomatic bacteriuria 56 gestational diabetes mellitus GDM 56 index BMI 56 nonobese patients 56 atherothrombosis 56 developmental trajectories 56 PLMs 56 haemodynamic 56 fasting triglyceride levels 56 neuropsychological impairments 56 pharmacokinetic interaction 56 #OHD levels 56 microscopic colitis 56 Calorie intake 56 DSM IV SCID 56 adnexal mass 56 Cotinine 56 glomerular filtration 56 lymphocyte count 56 allostatic load 56 HIV tropism 56 heterozygous familial 56 WOMAC pain 56 homocysteine concentrations 56 CSF biomarkers 56 dietary intakes 56 transaminase elevations 56 self directedness 56 decrements 56 aortic calcification 56 aortic stiffness 56 postoperative infections 56 Viral load 56 lipid concentrations 56 EEG abnormalities 56 tHcy 56 Negative Symptoms 56 Suboptimal 56 pharmacologic treatments 56 familial predisposition 56 confounding factors 56 untreated hypothyroidism 56 atheromatous 56 serum potassium 56 CSHCN 56 dyslipidemia hypertension 56 Outcome Measures 56 haematologic 56 semistructured interview 56 cardiometabolic risk 56 Predisposition 56 recurrent tonsillitis 56 obstetric complications 56 OSAHS 56 recurrent ischemia 56 mL/min/#.# m 2 56 df = 56 hyperarousal 56 aetiological 56 psychobiological 56 subjective sleepiness 56 prepregnancy weight 56 serum aminotransferase levels 56 baseline serum creatinine 56 serum glucose 56 Health Initiative Observational 56 familial AF 56 Exclusion criteria 56 urbanicity 56 hemoglobin A1c HbA1c 56 plasma leptin 56 Myocardial infarction 56 airway responsiveness 56 serum uric acid 56 colon rectal 56 2D 4D ratio 56 postprocedure 56 chromium picolinate supplementation 56 BRCA mutation carriers 56 familial pancreatic cancer 56 folate concentrations 56 anal HPV 56 PSADT 56 Disordered eating 56 fasting plasma 56 urinary albumin excretion 55 myocardial infarctions MIs 55 risk reducing salpingo 55 laterality 55 SCK difficulty 55 bacterial prostatitis 55 pathologic fractures 55 adenomatous polyps 55 actigraphy 55 serum concentrations 55 dichotomized 55 nodal metastases 55 undergoing coronary angiography 55 maternal morbidity 55 folate vitamin B 55 avoidant personality disorder 55 FFR measurements 55 mucosal inflammation 55 Gestational age 55 neurologic complications 55 distal radial fractures 55 coinfection 55 visceral metastases 55 Longitudinal studies 55 Hip fracture 55 antiarrhythmic medications 55 urinary cadmium 55 body habitus 55 PSQI 55 SMBG 55 HHAs 55 HF hospitalization 55 Winkleby 55 bispectral index BIS 55 tHcy concentrations 55 Stent thrombosis 55 Replication NCS R 55 emotional dysregulation 55 anti Mullerian hormone 55 multicentre prospective 55 baroreflex sensitivity 55 Pharmacologic 55 % CI #.#-#.# [004] 55 Low birthweight 55 thromboembolic 55 unstable angina pectoris 55 variant rs# 55 creatinine levels 55 aneurysmal subarachnoid hemorrhage 55 Seattle Angina Questionnaire 55 NMIBC 55 annualized relapse 55 androgen suppression 55 aspartate aminotransferase AST 55 hypercalciuria 55 Postnatal depression 55 left ventricular systolic 55 immunosuppression therapy 55 tricyclic antidepressants TCAs 55 syncopal episode 55 Secondhand smoke exposure 55 Multiple linear regression 55 % CI #.#-#.# [007] 55 Related Conditions NESARC 55 Lumbar spine 55 overt hypothyroidism 55 microalbuminuria 55 plasma pharmacokinetics 55 VADT 55 subscores 55 N telopeptide 55 intermittent exotropia 55 CIBIC + 55 P ≤ 55 hereditary predisposition 55 Operative mortality 55 tumor subtypes 55 neurologic abnormalities 55 Prognostic 55 highly heritable 55 NNT = 55 manic hypomanic 55 pulmonary dysfunction 55 Regression analyzes 55 retrospective cohort study 55 normal birthweight 55 HbA1c levels 55 perioperative morbidity 55 triglyceride concentrations 55 alcoholic liver cirrhosis 55 lignan intake 55 HIV coinfected 55 postinjury 55 HDL cholesterol triglycerides 55 AUDs 55 serum ferritin 55 inhospital 55 urinary cortisol 55 neuropsychological evaluations 55 hematologic parameters 55 dietary glycemic index 55 polyp recurrence 55 definite stent thrombosis 55 neuritic 55 adrenal function 55 SGAs 55 CKD MBD 55 % CI #.#-#.# [002] 55 medication nonadherence

Back to home page